I​‌‍‍‍‌‍‍‌‍‌‌‍‍‍‌‍‌‌‌‍​n our dialogue this week, consider that Coronavirus (aka, COVID-19) has resulted in a pandemic outbreak to date not seen in our lifetime. This has led to quarantine (which many, unfortunately, resisted), travel restrictions, widespread medical concerns, need for new vaccine creation and equitable vaccine distribution, etc. What regulatory/quality interventions would be appropriate to address this pandemic in both the short- and long-term? What regulatory agencies should be involved (careful, agencies like NIH are not regulatory, although vast in their expertise), and what should be the extent of their powers​‌‍‍‍‌‍‍‌‍‌‌‍‍‍‌‍‌‌‌‍​? Consider the following articles in your thoughts: